Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 10-2013 | 12-2012 | |
| Sales | 0 | 0 | 0 | 340 | 0 |
| Cost of Goods | N/A | N/A | N/A | 131 | N/A |
| Gross Profit | N/A | N/A | N/A | 209 | 10 |
| Operating Expenses | 4,317 | 2,732 | 120 | 347 | 7 |
| Operating Income | -4,317 | -2,732 | -120 | -7 | -7 |
| Interest Expense | 0 | 0 | 0 | 2 | 0 |
| Other Income | -522 | 0 | 0 | 6 | 1 |
| Pre-tax Income | -4,839 | -2,732 | -120 | -4 | -6 |
| Income Tax | 2 | 3 | N/A | N/A | N/A |
| Net Income Continuous | -4,841 | -2,734 | -120 | -4 | -6 |
| Net Income | $-4,841 | $-2,734 | $-120 | $-4 | $5 |
| EPS Basic Total Ops | -72.50 | -67.50 | -5.00 | 0.00 | N/A |
| EPS Basic Continuous Ops | -71.45 | -66.41 | -3.87 | -0.30 | N/A |
| EPS Diluted Total Ops | -72.50 | -67.50 | -5.00 | 0.00 | N/A |
| EPS Diluted Continuous Ops | -71.45 | -66.41 | -3.87 | -0.30 | N/A |
| EBITDA(a) | $-3,722 | $-2,730 | $-120 | $4 | $-7 |